Virginia Retirement Systems’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Virginia Retirement Systems’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-26,700	Closed	-$519K	–	1054
2023 Q2	$519K	Buy	26,700 +4,800	+22%	+$114K	0.01%	710
2023 Q1	$621K	Hold	21,900	–	–	0.01%	680
2022 Q4	$640K	Buy	21,900 +4,800	+28%	+$153K	0.01%	757
2022 Q3	$452K	Buy	+17,100	New	+$627K	0.01%	828
2022 Q1	$238K	Hold	4,800	–	–	﹤0.01%	1027
2021 Q4	$244	Buy	+4,800	New	+$249K	﹤0.01%	1017
2019 Q2	–	Sell	-21,900	Closed	-$1.11M	–	1185
2019 Q1	$1.11M	Buy	21,900 +700	+3%	+$31.1K	0.01%	643
2018 Q4	$854K	Buy	21,200 +9,300	+78%	+$479K	0.01%	677
2018 Q3	$825K	Buy	11,900 +1,500	+14%	+$114K	0.01%	770
2018 Q2	$787K	Sell	10,400 -1,600	-13%	-$101K	0.01%	763
2018 Q1	$632K	Buy	+12,000	New	+$698K	0.01%	784

Other funds holding EGRX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Virginia Retirement Systems's EGRX Position: Q3 2023 in Review

Virginia Retirement Systems sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2023, closing a stake of 26,700 shares — an estimated $519K sold.

Virginia Retirement Systems first reported a position in EGRX in Q1 2018 and held it in 11 quarters. The position peaked at $1.11M in Q1 2019. 107 funds tracked by Wall St. Rank hold EGRX as of Q3 2023.

Virginia Retirement Systems reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Virginia Retirement Systems sold 26,700 Eagle Pharmaceuticals, Inc. shares in Q3 2023, an estimated $519K.
Virginia Retirement Systems first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2018 and held it in 11 quarters.
Virginia Retirement Systems's Eagle Pharmaceuticals, Inc. position peaked at $1.11M in Q1 2019.
107 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.